0576-88813233
RG7834 (RO 7020322) is a highly selective and orally bioavailable inhibitor of HBV. RG7834 potently inhibits HBsAg, HBeAg, and HBV DNA, with IC50 of 2.8 nM, 2.6 nM, and 3.2 nM, respectively, in dHepaRG cells.
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司